The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

August 30, 2023

Study Completion Date

October 27, 2023

Conditions
Glaucoma
Interventions
DIAGNOSTIC_TEST

MIMS

This study is an extension follow up study conducted in continuation of the prior MIMS® study (see: STUDY ID: MMS EEU-1), in which the long-term (i.e., 28, 36, 42 months) clinical outcomes of Minimally Invasive Micro Sclerostomy System \[MIMS® System\] \[CE Marked device\] are evaluated.

Trial Locations (1)

Unknown

Malayan, Yerevan

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY